1Shames BD, Barton HH, Reznikov LL, et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock, 2002,17:114-119. 被引量：1
2Stamm C, Friehs I, Cowan DB, et al. Inhibition of tumor necrosis factor-alpha improves postischemia recovery of hypertrophied hearts. Circulation, 2001,104(12 suppl 1):I 350-355. 被引量：1
3Bozkurt B, Kribbs SB, Clubb FJ, et al. Pathophysiologically relrvantconcentration of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation, 1998,97:1382-1391. 被引量：1
4Sivasubramanian N, Coker ML, Kurrelmeyer KM, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation, 2001,104:826-831. 被引量：1
5Kadokami T, Frye C, Lemster B, et al. Anti- tumor necrosis factor alpha antibody limits heart failure in a transgenic model. Circulation, 2001,104:1094-1097. 被引量：1
6Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail, 2001,7:176-182. 被引量：1
7Sugano M, Koyangi M, Tsuchida K, et al. In vivo gene transfer of soluble TNF-alpha receptor 1 alleviates myocardial infarction. FASEB-J, 2002,16:1421-1422. 被引量：1
8Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept in patients with advanced heart failure. Circulation, 2001,103:1044-1047. 被引量：1
10Dekkers PE, Lanw FN, ten-Hove T, et al. The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor (TNF) and TNF receptors during Human endotoxemia. Blood, 1999,94:2252-2258. 被引量：1
2Aronow WS · Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure [ J ]. Cardiol Rev, 2006,14 ( 3 ) : 108. 被引量：1
3Yue p, Massie BM, Simposin PC , et al. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure[J].Am J Physiol , 1998, 275(1Pt2) : 250. 被引量：1
4McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure : the Framingham study [ J ]. N Engl J Med,1971,285(26) :1441 -1446. 被引量：1
5Peeters P, Mets T. The 6-minute walk as an appropriate ex- ercise test in elderly patients with chronic heart failure[ J]. J Gerontol A Biol Sci Med Sci,1996,51 (4):147 -151. 被引量：1
6Selvais PL, Donckier JE. Cardiac natriuretic peptides for di- agnosis and risk stratification in heart failure:influences of left vent ricular dysfunction and coronary artery disease on cardiac hormonal activation [ J ]. Eur J Invest, 1995,28 (8) :636. 被引量：1
7Barbieri A,Bursi F,Politi L,et al.Echocardiographic diastolic dysfunction and magnetic resonance infarct size in healed myocardial infarction treated with primary angioplasty.Echocardiography,2008,25:575-583. 被引量：1
8Martina B,Martin L,Birgit S,et al.Characterization of the rat,mouse,and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1(GDF-15/MIC-1).Gene,1999,237:105-111. 被引量：1
9Wang F,Guo Y,Yu H,et al.Growth differentiation factor15in different stages of heart failure:potential screening implications.Biomarkers,2010,15:671-676. 被引量：1
10Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Revise the1999Guidelines for the Management of Patients With Acute Myocardial Infarction).Circulation,2005,111:2013. 被引量：1
